共 101 条
- [1] Sarnak MJ(2002)Anemia as a risk factor for cardiovascular disease in the atherosclerosis risk in communities (ARIC) study J Am Coll Cardiol 40 27-33
- [2] Tighiouart H(2018)Anemia in patients with acute coronary syndromes treated with prasugrel or ticagrelor: insights from the RENAMI registry Thromb Res 167 142-148
- [3] Manjunath G(2009)Ticagrelor versus clopidogrel in patients with acute coronary syndromes N Engl J Med 361 1045-1057
- [4] MacLeod B(2021)Low hemoglobin predicts high-platelet reactivity and major cardiovascular ischemic events at long-term follow-up among ACS patients receiving dual antiplatelet therapy with ticagrelor Catheter Cardiovasc Interv 98 1309-1316
- [5] Griffith J(2020)Comparison between Ticagrelor and Clopidogrel in Elderly patients with an Acute Coronary Syndrome: insights from the SWEDEHEART Registry Circulation 142 1700-1708
- [6] Salem D(2005)Association of hemoglobin levels with clinical out- comes in acute coronary syndromes Circulation 111 2042-2049
- [7] Levey AS(2010)Relationship between baseline haemoglobin and major bleeding complications in acute coronary syndromes Eur Heart J 31 50-58
- [8] Guerrero C(2017)Derivation and valida- tion of the predicting bleeding complications in patients undergoing stent implantation and subsequent dual antiplatelet therapy (PRECISE-DAPT) score: a pooled analysis of individual-patient datasets from clinical trials Lancet 389 1025-1034
- [9] Garay A(2021)De-escalation of dual antiplatelet therapy in patients with acute coronary syndromes J Am Coll Cardiol 78 763-777
- [10] Ariza-Solé A(2017)Benefit of switching dual antiplatelet therapy after acute coronary syndrome: the TOPIC (timing of platelet inhibition after acute coronary syndrome) randomized study Eur Heart J 38 3070-3078